Full Press Release Details
REGENERON REPORTS THIRD QUARTER FINANCIAL AND OPERATING RESULTS FDA Grants Fast Track Designation to the VEGF Trap for Specific Cancer Indication.
REGN
REGENERON REPORTS THIRD QUARTER FINANCIAL AND OPERATING RESULTS FDA Grants Fast Track Designation to the VEGF Trap for Specific Cancer Indication
Key Takeaway: REGENERON REPORTS THIRD QUARTER FINANCIAL AND OPERATING RESULTS FDA Grants Fast Track Designation to the VEGF Trap for Specific Cancer Indication